Evaluating questionnaires for measuring radiation side effects
Official title: Prospective Evaluation of the Relation Between Different Questionnaires Measuring Radiation-induced Side-effect
Run by M.D. Anderson Cancer Center · NCT06295783 · Data updated 2026-11-12
This study tests different surveys to see how well they help patients with head and neck cancer describe their side effects from radiation therapy.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | June 10, 2024 |
| Main results expected | February 1, 2027 |
| Study ends | February 1, 2027 |
| Registry record updated | July 14, 2026 |
| Trial ID | NCT06295783 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a diagnosis of head and neck cancer who are currently undergoing or have recently completed radiation therapy.
✕Probably not a fit
Patients under 18, non-English speakers, or those with neurocognitive deficits that prevent them from completing surveys may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess how patients rate the intensity of their symptoms during or after radiation therapy using various questionnaires with different scoring systems. It focuses on translating the results of these questionnaires to understand their correlation and reliability. Participants will complete surveys designed to measure the side effects of radiation therapy, specifically in patients with head and neck cancer. The study will analyze the data to improve the understanding of patient-reported outcomes in radiation treatment.
Why it matters
Potential benefit: If successful, this study could enhance the accuracy of symptom assessment for patients undergoing radiation therapy, leading to better management of side effects.
How similar studies have gone: Other studies have shown success in using patient-reported outcome measures to assess treatment side effects, making this approach both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * English as a primary language * Participants with a diagnosis of HNC undergoing active curative RT or having received curative RT within the past 5 years at MD Anderson * Ability to complete the survey(s) of their own volition Exclusion Criteria: * Age \< 18 years * Non-English speaking participants * Participants who are receiving or have received RT in a non-HN site. * Participants in follow up and over 5 years from post-treatment * Neurocognitive deficits that render patients unable to complete the survey(s) on their own.
Where it's running
-
MD Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Amy Moreno, MD — M.D. Anderson Cancer Center
- Study coordinator: Amy Moreno, MD
- Email: akmoreno@mdanderson.org
- Phone: (713) 745-4590
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Baseline anxiety patterns in children receiving radiation therapy
This project will track how anxiety changes during radiation treatment in children ages 2–12 to see if specific visits or conditions make anxiety worse.
-
Motion tracking during lung cancer radiotherapy using real-time MRI
A trial tests real-time tracking of lung tumor motion during radiation therapy in adults with certain stages of NSCLC to see if MRI can help guide treatment.
-
Short-course radiotherapy followed by AK112 in mid-low rectal cancer with pMMR/MSS
This trial tests whether a short course of pelvic radiotherapy plus the IV drug ivonesimab (AK112) can produce a complete response in adults with a certain type of rectal cancer.
-
Combining chemoimmunotherapy with radiation for extensive stage small-cell lung cancer
This study is testing if combining a new type of cancer treatment with radiation can help people with advanced small-cell lung cancer live longer and feel better.
-
Improving radiation protection using genomic analysis
This study is testing if analyzing DNA changes in blood samples can help us understand how some people are better at handling radiation exposure than others.
-
Guiding radiation treatment for certain breast cancer patients
This study tests if skipping regional radiation for certain breast cancer patients who are at low risk can lead to better health outcomes after surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.